Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

16.1K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.1K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

9.7K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
9.7K
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

3.4K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.

Journal of hematology & oncology·2026
Same author

Reactive and therapy induced bone marrow changes linked to systemic infectious and non-infectious disorders including MAS/HLH report from the European association for haematopathology, Dubrovnik 2024.

Virchows Archiv : an international journal of pathology·2026
Same author

Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation study.

The Lancet. Haematology·2026
Same author

Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa study.

Haematologica·2026
Same author

Prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after CAR T-cell therapy relapse.

Haematologica·2026
Same author

A subset of histamine H4 receptor antagonists prevents B lymphocyte proliferation induced by BCR/TLR9 engagement or EBV infection.

Antiviral research·2026

相关实验视频

Updated: Feb 22, 2026

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

876

[边缘区域淋巴瘤的最新情况]

Marie Donzel1, Lucile Baseggio2, Camille Laurent3

  • 1Institut de pathologie multisite, hospices civils de Lyon, Lyon, France; Université Claude-Bernard Lyon 1, 69100 Villeurbanne, France; Centre international de recherche en infectiologie (CIRI), Institut national de la santé et de la recherche médicale (Inserm) U1111, Centre national de la recherche scientifique (CNRS), UMR5308, École normale supérieure de Lyon, Lyon, France.

Annales de pathologie
|February 20, 2026
PubMed
概括

本次审查涵盖了五种边缘区域淋巴瘤 (MZL) 亚型,包括新定义的儿科和皮肤形式. 它强调了共同和独特的特征,专注于分子数据以改善诊断.

关键词:
额外的边缘区域淋巴瘤.无意识的B细胞淋巴瘤淋巴瘤 B 沉默的 淋巴瘤 B 沉默的边缘区域的淋巴瘤淋巴瘤的区域边缘性外性淋巴瘤.淋巴瘤的区域边缘原始皮肤.脊髓边缘区域的淋巴瘤 脊髓边缘区域的淋巴瘤淋巴细胞的扩散.淋巴细胞的扩散.马尔特 马尔特 马尔特边缘区域淋巴瘤 边缘区域淋巴瘤原发性皮肤边缘区域淋巴瘤脏边缘区域淋巴瘤脏边缘区域淋巴瘤

更多相关视频

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K
Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

12.2K

相关实验视频

Last Updated: Feb 22, 2026

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

876
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K
Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

12.2K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 病理学 病理学 病理学

背景情况:

  • 2022年世界卫生组织和ICC分类界定了五个边缘区域淋巴瘤 (MZL) 实体.
  • 这些包括 extranodal MZL (MALT淋巴瘤),结节MZL (NMZL),脏MZL (SMZL),儿科结节MZL (PNMZL) 和初级皮肤MZL (PC-MZL).
  • 虽然共享共同的特征,但每个MZL亚型都表现出独特的特征.

研究的目的:

  • 审查新定义的儿科结节边缘区域淋巴瘤 (PNMZL) 和初级皮肤边缘区域淋巴瘤 (PC-MZL) 实体.
  • 讨论与边缘区域淋巴瘤诊断相关的最新分子数据.
  • 提供公认的MZL亚型的最新概述.

主要方法:

  • 最近的分类和分子研究的文献综述.
  • 在MZL亚型中对形态,免疫类型和遗传特征进行比较分析.
  • 专注于新的实体和诊断进步.

主要成果:

  • 认可了五个不同的MZL实体,最近划分了PNMZL和PC-MZL.
  • 在MZL亚型中存在共同和独特的特征,影响诊断.
  • 新兴的分子数据为改善诊断准确性提供了潜力.

结论:

  • 对MZL亚型的准确分类对于适当的患者管理至关重要.
  • 对分子特征的进一步研究将提高诊断精度.
  • 审查强调了更新MZL的分类和诊断工具的重要性.